Shamburg News · 8-K filed Oct 30, 2026, 4:05 PM EDT
Allarity Therapeutics Terminates Common Stock Purchase Agreement with Tumim Stone Capital
ALLR · Allarity Therapeutics, Inc.
- Material agreement
- Financing
- Materiality: medium
On October 28, 2026, Allarity Therapeutics, Inc. terminated its Common Stock Purchase Agreement dated January 28, 2026 with Tumim Stone Capital LLC, which had allowed the company to sell up to $6.0 million of common stock at its discretion. The company stated it elected to terminate the agreement in connection with plans to pursue alternative financing arrangements. No early termination penalty is payable, and the company will not sell additional shares to Tumim under the agreement.
Source: SEC EDGAR, Form 8-K, Item 1.02, accession 0001213900-26-114380.
Written from the filing by Shamburg Markets. Figures are as reported by the company.